Findings from the American Diabetes Associations Annual Meeting
The American Diabetes Association meets every year in June to discuss recent research findings. Here’s a very brief summary of some of the latest research:
- People with diabetes who have heart bypass surgery usually have stents implanted, which keep the arteries propped open for better blood flow. But the stents themselves can sometimes cause scarring, which can cause re-blockage, or what’s called restenosis. A common blood-sugar-lowering drug, rosiglitazone, seems to decrease the incidence of restenosis, keeping patients from having to have further bypass surgery.
- Researchers are learning more about hormones found in the intestinal tract. These hormones seem to affect a person’s appetite and ability to feel satisfied after a meal. Researchers believe that information about these hormones can lead to new ways to treat the problems of obesity and type 2 diabetes.
- People who suffer with diabetic neuropathy may find relief from an epilepsy drug called topiramate. Other epilepsy medications have been used to treat neuropathy, but topiramate belongs to a new class of drugs. Using a medication in this way—for something other than its originally intended use—is called “off label use.” It’s important not to use any drug in this way without careful discussions with your doctor.
American Diabetes Association